# DOXYCYCLINE
> **ANDA216631** · Abbreviated New Drug Application (Generic) · Sponsor: LUPIN · Approved 2024-04-08
## Drug
- **FDA Application Number:** ANDA216631
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DOXYCYCLINE
- **Generic name:** DOXYCYCLINE
- **Active ingredients:** DOXYCYCLINE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** LUPIN
- **Manufacturer:** Lupin Pharmaceuticals, Inc.
- **First approval:** 2024-04-08
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216631)
---
*MORVS · CC0 1.0*